Researchers at Moffitt Cancer Center have developed a novel biomaterial-based system that induces the formation of tertiary lymphoid-like structures (TLSs). These immune cell clusters are increasingly linked to improved outcomes and treatment responses in cancer. Results of their study are published in the Proceedings of the National Academy of Sciences.